Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Addison's disease: a survey on 633 patients in Padova.

Betterle C, Scarpa R, Garelli S, Morlin L, Lazzarotto F, Presotto F, Coco G, Masiero S, Parolo A, Albergoni MP, Favero R, Barollo S, Salvà M, Basso D, Chen S, Rees Smith B, Furmaniak J, Mantero F.

Eur J Endocrinol. 2013 Oct 21;169(6):773-84. doi: 10.1530/EJE-13-0528. Print 2013 Dec.

2.

Adrenal autoantibodies and organ-specific autoimmunity in patients with Addison's disease.

Söderbergh A, Winqvist O, Norheim I, Rorsman F, Husebye ES, Dolva O, Karlsson FA, Kämpe O.

Clin Endocrinol (Oxf). 1996 Oct;45(4):453-60.

PMID:
8959085
3.

Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.

Wolff AS, Erichsen MM, Meager A, Magitta NF, Myhre AG, Bollerslev J, Fougner KJ, Lima K, Knappskog PM, Husebye ES.

J Clin Endocrinol Metab. 2007 Feb;92(2):595-603. Epub 2006 Nov 21.

PMID:
17118990
4.

Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease.

F Magitta N, Pura M, S Bøe Wolff A, Vanuga P, Meager A, M Knappskog P, Husebye ES.

Eur J Endocrinol. 2008 May;158(5):705-9. doi: 10.1530/EJE-07-0843.

5.

Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic, and immunological evaluation.

Reato G, Morlin L, Chen S, Furmaniak J, Smith BR, Masiero S, Albergoni MP, Cervato S, Zanchetta R, Betterle C.

J Clin Endocrinol Metab. 2011 Aug;96(8):E1255-61. doi: 10.1210/jc.2011-0414. Epub 2011 Jun 15.

PMID:
21677034
6.

Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies.

Coco G, Dal Pra C, Presotto F, Albergoni MP, Canova C, Pedini B, Zanchetta R, Chen S, Furmaniak J, Rees Smith B, Mantero F, Betterle C.

J Clin Endocrinol Metab. 2006 May;91(5):1637-45. Epub 2006 Mar 7.

PMID:
16522688
7.

Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features.

Myhre AG, Undlien DE, Løvås K, Uhlving S, Nedrebø BG, Fougner KJ, Trovik T, Sørheim JI, Husebye ES.

J Clin Endocrinol Metab. 2002 Feb;87(2):618-23.

PMID:
11836294
8.

Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays.

Betterle C, Volpato M, Pedini B, Chen S, Smith BR, Furmaniak J.

J Clin Endocrinol Metab. 1999 Feb;84(2):618-22.

PMID:
10022426
9.

Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.

Seissler J, Schott M, Steinbrenner H, Peterson P, Scherbaum WA.

Exp Clin Endocrinol Diabetes. 1999;107(3):208-13.

PMID:
10376448
10.

Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.

Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, Husebye ES, Furcas M, Rosatelli MC, Cao A, Congia M.

J Clin Endocrinol Metab. 2012 Apr;97(4):1114-24. doi: 10.1210/jc.2011-2461. Epub 2012 Feb 16.

PMID:
22344197
11.

Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure.

Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Rees Smith B, Furmaniak J.

J Clin Endocrinol Metab. 1996 May;81(5):1871-6.

PMID:
8626850
12.

21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry.

Falorni A, Laureti S, Nikoshkov A, Picchio ML, Hallengren B, Vandewalle CL, Gorus FK, Tortoioli C, Luthman H, Brunetti P, Santeusanio F.

Clin Exp Immunol. 1997 Feb;107(2):341-6.

13.

Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease.

Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, Brunetti P, Sanjeevi CB.

J Clin Endocrinol Metab. 1999 Oct;84(10):3701-7.

PMID:
10523017
14.

Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry.

Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES.

J Clin Endocrinol Metab. 2009 Dec;94(12):4882-90. doi: 10.1210/jc.2009-1368. Epub 2009 Oct 26.

PMID:
19858318
15.

DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease.

Yu L, Brewer KW, Gates S, Wu A, Wang T, Babu SR, Gottlieb PA, Freed BM, Noble J, Erlich HA, Rewers MJ, Eisenbarth GS.

J Clin Endocrinol Metab. 1999 Jan;84(1):328-35.

PMID:
9920103
16.
17.

HLA similarities indicate shared genetic risk in 21-hydroxylase autoantibody positive South African and United States Addison's disease.

Ross IL, Babu S, Armstrong T, Zhang L, Schatz D, Pugliese A, Eisenbarth G, Baker Ii P.

Tissue Antigens. 2014 Oct;84(4):361-9. doi: 10.1111/tan.12407. Epub 2014 Jul 18.

PMID:
25040682
18.

Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes.

Triolo TM, Baschal EE, Armstrong TK, Toews CS, Fain PR, Rewers MJ, Yu L, Miao D, Eisenbarth GS, Gottlieb PA, Barker JM.

J Clin Endocrinol Metab. 2009 Nov;94(11):4517-23. doi: 10.1210/jc.2009-1308. Epub 2009 Oct 9.

19.

Autoantibodies in autoimmune polyendocrine syndrome type II.

Falorni A, Laureti S, Santeusanio F.

Endocrinol Metab Clin North Am. 2002 Jun;31(2):369-89, vii. Review.

PMID:
12092456
20.

Autoimmune Addison's disease.

Betterle C, Morlin L.

Endocr Dev. 2011;20:161-72. doi: 10.1159/000321239. Epub 2010 Dec 16. Review.

PMID:
21164269

Supplemental Content

Support Center